As an important strategic layout of the listed company Tat Ka Wai Hong Pharmaceutical Group in the field of life and health, Tat Ka Wai Hong Regenerative Medicine Research Institute is committed to combining key core technology breakthroughs with clinical application solutions, focusing on the research and development of internationally leading cell medicine research technologies, cell Storage technology, cell quality detection technology, cell transplantation treatment and other technologies will comprehensively promote innovative technologies in the field of stem cells and the research and development of new pharmaceutical products, and strive to create a regenerative medicine innovation platform that integrates regenerative medicine research and development, achievement transformation, industrial incubation, and technical services. , leading the high-quality development of the regenerative medicine industry.